MedTrace Logo

Vitamin D Levels in Women With Polycystic Ovary Syndrome

NCT05101811 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-11-01

No results posted yet for this study

Summary

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Vitamin D Levels measurement using chemiluminescent assay

Measurement of serum vitamin D levels

DEVICE

Vitamin D level assessment

Using lIAISON DEVICE

Sponsors & Collaborators

  • Al-Azhar University

    collaborator OTHER

  • Ghamra Military Hospital

    lead OTHER

Principal Investigators

  • Osama Mohamed · Ghamra Military Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-04-01
Completion
2021-05-01
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05101811 on ClinicalTrials.gov